The experimental coronavirus treatment remdesivir has generated “positive data” in a trial of the antiviral organized by the National Institute of Allergy and Infectious Diseases (NIAID), according to developer Gilead Sciences.
from FOX News https://ift.tt/2KNq8fa
v
0 comments:
Post a Comment